Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103. | J Clin Oncol;11(12): 2405-10, 1993 Dec. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.

Trimble, E L; Adams, J D; Vena, D; Hawkins, M J; Friedman, M A; Fisherman, J S; Christian, M C; Canetta, R; Onetto, N; Hayn, R.

Affiliation

Trimble EL; Clinical Investigation Branch, National Cancer Institute, Rockville, MD 20852.

J Clin Oncol ; 11(12): 2405-10, 1993 Dec.

Article in En | MEDLINE | ID: mdl-7902426

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Carcinoma / Paclitaxel Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 1993 Document type: Article Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Carcinoma / Paclitaxel Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 1993 Document type: Article Country of publication: